At Avecris, we are developing an innovative genetic vector platform technology that will enable a new class of medicines. Our technology is: Universally programmable Scalable Redosable Non-integrating Cell-type specific Low cost
| Website | http://www.avecris.com |
| Employees | 5 (3 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Gene Therapy, Medicine Development, Platform Technology, Genetic Engineering, Scalable Manufacturing, Innovative Medicines, Gene Modification, Drug Delivery, Pharmaceutical Research, Low Cost Manufacturing, Novel Therapeutics, Biotechnology, Cell Therapy, Advanced Therapies |
| Competitors | ProBioGen AG, Genomatix AG, TAP People (The Automation Partnership / TAP Biosystems), Celerion, BioDuro-Sundia, Evotec, Sygnature Discovery, Charles River Laboratories, Labcorp, Research Pharmaceutical Services +40 more (view full list) |
Looking for a particular AVECRIS employee's phone or email?
AVECRIS Questions
Sushmita Poddar is the Director of Research and Development of AVECRIS.
3 people are employed at AVECRIS.
Top AVECRIS Employees
G2Crowd Trusted
300K+
Plugin Users
